Kristin Beale

Goodwin

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Celltrion Announces Commercial Availability of ZYMFENTRA™ (infliximab-dyyb)

Celltrion USA announced on March 18, 2024, the availability of ZYMFENTRA™ (infliximab-dyyb), a subcutaneous (SC) formulation of infliximab…...more

3/20/2024  /  Biologics , Biosimilars , FDA Approval , Food and Drug Administration (FDA) , Life Sciences , Pharmaceutical Industry , Prescription Drugs

Sandoz Receives FDA Approval for Tyruko® (natalizumab-sztn), the First and Only FDA-Approved Biosimilar for Relapsing Forms of...

​​​​​​​On August 25, 2023, Sandoz announced that the FDA has approved its biosimilar Tyruko® (natalizumab-sztn), developed by Polpharma Biologics. Tyruko® injection is the first and only FDA-approved biosimilar for relapsing...more

9/13/2023  /  Biosimilars , FDA Approval , Food and Drug Administration (FDA) , Pharmaceutical Industry , Prescription Drugs
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide